UOC
RENE

UBS O'Connor’s Cartesian Growth Corp II RENE Stock Holding History

UBS O'Connor’s Portfolio RENE Stock Details RENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-356,946
Closed -$4.24M – 443
2025
Q1 		$4.24M Hold
356,946
– – 0.1% 71
2024
Q4 		$4.16M Hold
356,946
– – 0.1% 94
2024
Q3 		$4.09M Sell
356,946
-11,532
-3% -$131K 0.1% 105
2024
Q2 		$4.16M Hold
368,478
– – 0.12% 117
2024
Q1 		$4.09M Hold
368,478
– – 0.12% 100
2023
Q4 		$4.04M Sell
368,478
-165,622
-31% -$1.8M 0.13% 94
2023
Q3 		$5.77M Hold
534,100
– – 0.1% 101
2023
Q2 		$5.7M Sell
534,100
-12,039
-2% -$127K 0.12% 100
2023
Q1 		$5.73M Buy
+546,139
New +$5.67M 0.14% 108

Other funds holding RENE

MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.29% 1-Year Est. Return

UBS O'Connor's RENE Position: Q2 2025 in Review

UBS O'Connor sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 356,946 shares — an estimated $4.24M sold.

UBS O'Connor first reported a position in RENE in Q1 2023 and held it in 9 quarters. The position peaked at $5.77M in Q3 2023. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • UBS O'Connor reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • UBS O'Connor sold 356,946 Cartesian Growth Corp II shares in Q2 2025, an estimated $4.24M.
  • UBS O'Connor first reported a position in Cartesian Growth Corp II in Q1 2023 and held it in 9 quarters.
  • UBS O'Connor's Cartesian Growth Corp II position peaked at $5.77M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on UBS O'Connor's 13F filing for Q2 2025, filed 14 Aug 2025.